Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Relay Therapeutics (RLAY) Shares Issued: 2019-2024

Historic Shares Issued for Relay Therapeutics (RLAY) over the last 6 years, with Dec 2024 value amounting to $17.9 million.

  • Relay Therapeutics' Shares Issued rose 2221.28% to $218.2 million in Q3 2024 from the same period last year, while for Sep 2024 it was $244.3 million, marking a year-over-year decrease of 16.84%. This contributed to the annual value of $17.9 million for FY2024, which is 40.92% down from last year.
  • As of FY2024, Relay Therapeutics' Shares Issued stood at $17.9 million, which was down 40.92% from $30.3 million recorded in FY2023.
  • Relay Therapeutics' Shares Issued's 5-year high stood at $425.3 million during FY2020, with a 5-year trough of $1.1 million in FY2021.
  • In the last 3 years, Relay Therapeutics' Shares Issued had a median value of $17.9 million in 2024 and averaged $16.6 million.
  • Per our database at Business Quant, Relay Therapeutics' Shares Issued spiked by 69,278.96% in 2020 and then crashed by 99.73% in 2021.
  • Relay Therapeutics' Shares Issued (Yearly) stood at $425.3 million in 2020, then slumped by 99.73% to $1.1 million in 2021, then skyrocketed by 47.77% to $1.7 million in 2022, then surged by 1,697.15% to $30.3 million in 2023, then plummeted by 40.92% to $17.9 million in 2024.